Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Jan 2026 for Protara Therapeutics, Inc., €18k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Patrick Fabbio: trading record in brief
Patrick Fabbio, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Protara Therapeutics, Inc. and Rafael Holdings, Inc. Between 1 February 2022 and 26 January 2026, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 27 January 2026: a share grant of €18k, in Protara Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Patrick Fabbio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
3,261 shares@ US$6.6739.0% of flowCommon StockSEC:0001213900-26-008221:0
3,063 shares@ US$5.6031.3% of flowCommon StockSEC:0001213900-26-006709:0
28,000 shares0Common StockSEC:0001213900-26-006230:0
23,500 shares0Common StockSEC:0001213900-25-007530:0
3,061 shares@ US$4.76100.0% of flowCommon StockSEC:0001213900-25-005966:0
22,000 shares0Common StockSEC:0001213900-24-005723:0
27,928 shares@ US$1.76100.0% of flowClass B Common Stock, par value $.01 per shareSEC:0001209191-22-062551:0
363,103 shares0Class B Common Stock, par value $.01 per shareSEC:0001209191-22-006650:0
8 of 8 declarations
